Metraipolis › archive › dc_2ec6506afba3

Immune checkpoint inhibition in bone metastases: lesion response heterogeneity, the osteoimmune niche, and microenvironment-directed therapy — Europe PMC PMID:42824795

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42824795
DOI
10.3389/fimmu.2026.1959101
License (as archived)
solo-consultazione
Archived
2026-10-08T09:37:42.149Z
SHA-256 of the archived text
0655541338d3ac8a08696f9000ddd946282b011ea078a66d5c51fdc3d36fb339
Stable URL of this page
https://metraipolis.com/documento/dc_2ec6506afba3

How to cite

Immune checkpoint inhibition in bone metastases: lesion response heterogeneity, the osteoimmune niche, and microenvironment-directed therapy — Europe PMC PMID:42824795 — Europe PMC (en), https://europepmc.org/article/MED/42824795 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ec6506afba3 (Metraipolis archive dc_2ec6506afba3, sha256 0655541338d3ac8a08696f9000ddd946282b011ea078a66d5c51fdc3d36fb339)
BibTeX
@misc{dc2ec6506afba3,
  title = {Immune checkpoint inhibition in bone metastases: lesion response heterogeneity, the osteoimmune niche, and microenvironment-directed therapy — Europe PMC PMID:42824795},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42824795},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ec6506afba3; sha256 0655541338d3ac8a08696f9000ddd946282b011ea078a66d5c51fdc3d36fb339},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42824795. Agents can read the archived copy with the MCP tool read_document.